Smith & Nephew plc (LON:SN.)

Market Cap	10.61B +3.6%
Revenue (ttm)	4.58B +6.1%
Net Income	464.38M +51.7%
EPS	0.53 +52.3%
Shares Out	849.89M
PE Ratio	23.46
Forward PE	14.79
Dividend	0.29 (2.36%)
Ex-Dividend Date	Mar 26, 2026

Volume	1,741,490
Average Volume	2,605,875
Open	1,233.50
Previous Close	1,240.50
Day's Range	1,231.50 - 1,250.50
52-Week Range	937.80 - 1,441.50
Beta	0.68
RSI	41.72
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 17,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SN.

Financial Performance

In 2025, Smith & Nephew's revenue was $6.16 billion, an increase of 6.09% compared to the previous year's $5.81 billion. Earnings were $625.00 million, an increase of 51.70%.

Financial numbers in USD